VIDEO: Newly defined syndrome is a ‘brilliant concept’ on stages of CVD risk
Click Here to Manage Email Alerts
BOSTON — Cardiovascular-kidney-metabolic syndrome, or CKM, is a new term endorsed by the American Heart Association that reflects the interplay of metabolic and renal conditions that drive the risk for CVD.
In this video, Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA, a professor and chief of cardiology at Northwestern University Feinberg School of Medicine, discusses “this brilliant concept” that he said underscores the role of adiposity in hepatic, renal and cardiovascular changes.
This is part of a six-video Healio Video Exclusive in which Yancy recaps his talk at the ACP Internal Medicine Meeting on important updates in cardiology.
Read the full article on Yancy’s talk here and check out the other videos in this series:
- VIDEO: New CVD risk algorithm incorporates social determinants of health
- VIDEO: Cardiovascular benefits of GLP-1 agonists ‘absolutely stunning’
- VIDEO: Small interfering RNA holds promise for cardiovascular care
- VIDEO: Use incidental calcification findings to estimate CVD risk
- VIDEO: Following Life’s Essential 8 leads to ‘much better outcomes’
Reference:
- Yancy CW. Update in cardiology. Presented at: ACP Internal Medicine Meeting; April 18-20, 2024; Boston.